Alterations of Lipid Metabolism in Cancer: Implications in Prognosis and Treatment

被引:144
作者
Fernandez, Lara P. [1 ]
Gomez de Cedron, Marta [1 ]
Ramirez de Molina, Ana [1 ]
机构
[1] Univ Autonomous Madrid UAM CSIC, Precis Nutr & Canc Program, Mol Oncol Grp, IMDEA Food Inst, Campus Int Excellence CEI, Madrid, Spain
关键词
lipid metabolism; cancer prognosis; tumor microenviroment (TME); obesity; cancer risk; precision medicine; precision nutrition; FATTY-ACID SYNTHASE; STEAROYL-COA-DESATURASE; HUMAN BREAST-CANCER; ATP-CITRATE LYASE; CELL LUNG-CANCER; ACTIVATED RECEPTOR-GAMMA; CHOLESTERYL ESTER ACCUMULATION; MESSENGER-RNA LEVELS; COLORECTAL-CANCER; PROSTATE-CANCER;
D O I
10.3389/fonc.2020.577420
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer remains the second leading cause of mortality worldwide. In the course of this multistage and multifactorial disease, a set of alterations takes place, with genetic and environmental factors modulating tumorigenesis and disease progression. Metabolic alterations of tumors are well-recognized and are considered as one of the hallmarks of cancer. Cancer cells adapt their metabolic competences in order to efficiently supply their novel demands of energy to sustain cell proliferation and metastasis. At present, there is a growing interest in understanding the metabolic switch that occurs during tumorigenesis. Together with the Warburg effect and the increased glutaminolysis, lipid metabolism has emerged as essential for tumor development and progression. Indeed, several investigations have demonstrated the consequences of lipid metabolism alterations in cell migration, invasion, and angiogenesis, three basic steps occurring during metastasis. In addition, obesity and associated metabolic alterations have been shown to augment the risk of cancer and to worsen its prognosis. Consequently, an extensive collection of tumorigenic steps has been shown to be modulated by lipid metabolism, not only affecting the growth of primary tumors, but also mediating progression and metastasis. Besides, key enzymes involved in lipid-metabolic pathways have been associated with cancer survival and have been proposed as prognosis biomarkers of cancer. In this review, we will analyze the impact of obesity and related tumor microenviroment alterations as modifiable risk factors in cancer, focusing on the lipid alterations co-occurring during tumorigenesis. The value of precision technologies and its application to target lipid metabolism in cancer will also be discussed. The degree to which lipid alterations, together with current therapies and intake of specific dietary components, affect risk of cancer is now under investigation, and innovative therapeutic or preventive applications must be explored.
引用
收藏
页数:24
相关论文
共 298 条
[1]   Prognostic and biological significance of peroxisome proliferator-activated receptor-gamma in luminal breast cancer [J].
Abduljabbar, Rezvan ;
Al-Kaabi, Methaq Mueen ;
Negm, Ola H. ;
Jerjees, Dena ;
Muftah, Abir A. ;
Mukherjee, Abhik ;
Lai, Chun F. ;
Buluwela, Laki ;
Ali, Simak ;
Tighe, Patrick J. ;
Green, Andrew ;
Ellis, Ian ;
Rakha, Emad .
BREAST CANCER RESEARCH AND TREATMENT, 2015, 150 (03) :511-522
[2]   Effects of resveratrol and other polyphenols in hepatic steatosis [J].
Aguirre, Leixuri ;
Puy Portillo, Maria ;
Hijona, Elizabeth ;
Bujanda, Luis .
WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (23) :7366-7380
[3]   ABCA1 overexpression worsens colorectal cancer prognosis by facilitating tumour growth and caveolin-1-dependent invasiveness, and these effects can be ameliorated using the BET inhibitor apabetalone [J].
Aguirre-Portoles, Cristina ;
Feliu, Jaime ;
Reglero, Guillermo ;
Ramirez de Molina, Ana .
MOLECULAR ONCOLOGY, 2018, 12 (10) :1735-1752
[4]   Precision Nutrition for Targeting Lipid Metabolism in Colorectal Cancer [J].
Aguirre-Portoles, Cristina ;
Fernandez, Lara P. ;
Ramirez de Molina, Ana .
NUTRIENTS, 2017, 9 (10)
[5]   Fatty acid oxidation is associated with proliferation and prognosis in breast and other cancers [J].
Aiderus, Aziz ;
Black, Michael A. ;
Dunbier, Anita K. .
BMC CANCER, 2018, 18
[6]   Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5 [J].
Al-Jameel, Waseem ;
Gou, Xiaojun ;
Forootan, Shiva S. ;
Al Fayi, Majed Saad ;
Rudland, Philip S. ;
Forootan, Farzad S. ;
Zhang, Jiacheng ;
Cornford, Philip A. ;
Hussain, Syed A. ;
Ke, Youqiang .
ONCOTARGET, 2017, 8 (19) :31041-31056
[7]   Fatty acid synthase inhibitors are chemopreventive for mammary cancer in neu-N transgenic mice [J].
Alli, PM ;
Pinn, ML ;
Jaffee, EM ;
McFadden, JM ;
Kuhajda, FP .
ONCOGENE, 2005, 24 (01) :39-46
[8]   Fasnall, a Selective FASN Inhibitor, Shows Potent Anti-tumor Activity in the MMTV-Neu Model of HER2+ Breast Cancer [J].
Alwarawrah, Yazan ;
Hughes, Philip ;
Loiselle, David ;
Carlson, David A. ;
Darr, David B. ;
Jordan, Jamie L. ;
Xiong, Jessie ;
Hunter, Lucas M. ;
Dubois, Laura G. ;
Thompson, J. Will ;
Kulkarni, Manjusha M. ;
Ratcliff, Annette N. ;
Kwiek, Jesse J. ;
Haystead, Timothy A. J. .
CELL CHEMICAL BIOLOGY, 2016, 23 (06) :678-688
[9]  
Amir M, 2011, EXPERT REV GASTROENT, V5, P159, DOI [10.1586/egh.11.4, 10.1586/EGH.11.4]
[10]   Screening of core genes and pathways in breast cancer development via comprehensive analysis of multi gene expression datasets [J].
Bai, Jie ;
Zhang, Xiaoyu ;
Kang, Xiaoning ;
Jin, Lijun ;
Wang, Peng ;
Wang, Zunyi .
ONCOLOGY LETTERS, 2019, 18 (06) :5821-5830